ANG Lifesciences India Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 185.46 million compared to INR 469.26 million a year ago. Revenue was INR 185.16 million compared to INR 471.65 million a year ago. Net loss was INR 59.31 million compared to INR 17.76 million a year ago. Basic loss per share from continuing operations was INR 4.52 compared to INR 1.36 a year ago. Diluted loss per share from continuing operations was INR 4.52 compared to INR 1.36 a year ago.
For the nine months, sales was INR 1,082.7 million compared to INR 1,804.54 million a year ago. Revenue was INR 1,087.8 million compared to INR 1,809.45 million a year ago. Net loss was INR 64.96 million compared to net income of INR 43.47 million a year ago. Basic loss per share from continuing operations was INR 4.86 compared to basic earnings per share from continuing operations of INR 3.99 a year ago. Diluted loss per share from continuing operations was INR 4.86 compared to diluted earnings per share from continuing operations of INR 3.99 a year ago.